Studies from other laboratories showed that increased level of intracellular NAD+ enhanced the activities of SIRT1 and SIRT3 33, which in turn, suppressed cardiac hypertrophy through the activation of Foxo3a‐dependent antioxidant defence mechanism 34. This evidence concerns the gene FOXO3 and cardiac hypertrophy.